Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 1200-1205, June 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pilgrim, H. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pilgrim, H. I.

The Kinetics of the Organ-specific Metastasis of a Transplantable Reticuloendothelial Tumor1

H. Ira Pilgrim

The Germfree Laboratory, Department of Surgery, University of Utah College of Medicine, Salt Lake City, Utah 84112

Reticuloendothelial tumors tend to metastasize to specific organs and are, therefore, ideal tools for testing the "seed-soil hypothesis" of metastasis.

A transplantable reticulum-cell sarcoma which selectively metastasizes to the spleen was used. Equal numbers of cells were injected into both kidney and spleen of six C3H mice. At the time of sacrifice, growth in the spleen was always considerably greater than in the kidney. In no case was the mitotic index greater in the spleen than the kidney. Since the growth rate equals the mitotic rate minus the cell loss rate, one may conclude that the reason for the relative lack of growth in the kidney is that the rate of tumor cell loss is greater there than in the spleen. Additional studies demonstrate that these tumor cells will migrate to the spleen if implanted in other locations, including the kidney. This tendency to migrate out of organs other than the spleen may account for the apparent selective metastatic behavior of this tumor.

1 Supported by USPHS Research Carcer Program Award CA-19,034 and Grant CA 05771 from the National Cancer Institute, NIH.

Received 9/16/68. Accepted 1/17/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.